Featured post

Holdings in Company

 

The attached TR1 notification relates to the shareholding in Source BioScience held by Henderson Global Investors, which now stands at 40,780,520 shares, representing 13.01% of the Company’s ordinary share capital.

 

Latest News

Source BioScience launches its products and services in the USA

1 Apr 2014

Source BioScience today announces the launch of its US business operating out of facilities in Los Angeles and Atlanta. The Company will hold a ribbon cutting ceremony today as its Los Angeles site to celebrate the launch.

Read more »

Preliminary results for the year ended 31 December 2013

18 Mar 2014

The Board of Source BioScience plc today announces its unaudited results for the year ended 31 December 2013.

Read more »

Notice of Results

6 Mar 2014

Source BioScience will be announcing its preliminary results for the year ended 31 December 2013 on Tuesday 18th March 2014.

Read more »

Alex Salmond opens Source BioScience's Scottish sequencing lab

17 Feb 2014

Alex Salmond opens Source BioScience's Scottish sequencing lab

Read more »

Source BioScience opens new DNA sequencing facility in Tramore

3 Feb 2014

Source BioScience has expanded its market leading DNA sequencing service in Ireland with the official opening of its new laboratory in Tramore, County Waterford.

Read more »

Total Voting Rights

31 Jan 2014

In accordance with the FCA's Disclosure and Transparency Rules, Source BioScience plc confirms that as at 31 January 2014 the Company has 313,448,965 ordinary shares of 2 pence each in issue. The figure of 313,448,965 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, Source BioScience plc under the FCA’s Disclosure and Transparency Rules. The voting rights of all ordinary shares in the Company rank pari passu and the Company does not hold any ordinary shares in treasury.

Read more »